FLT3 and leukemia: Partial knockdown of the transcription factor STAT5 (STAT5A and STAT5B) in FLT3-ITD cells resulted in decreased ROS production [263], highlighting the oncogenic association between recurring somatic mutations and the necessity for leukaemia cells to maintain a state of oxidative dysfunction.